Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of a randomized, double-blind, placebo-controlled, 2-way crossover study is to
evaluate the efficacy, safety/tolerability and pharmacokinetics of JM-010 for the treatment
of subjects with Parkinson's Disease (PD) with levodopa-induced dyskinesia (LID).